Japan filing for Nexavar in thyroid cancer
This article was originally published in Scrip
Bayer has submitted a regulatory filing in Japan seeking the approval of Nexavar (sorafenib) for the additional indication of locally advanced or metastatic thyroid cancer.
You may also be interested in...
Novel antifungal T-2307, discovered by FUJIFILM Toyama, works by selectively disrupting mitochondrial function. Excelra and Maruho team up to repurpose existing drugs.
Diversified Japanese giant to launch tender for Danish transplant drug specialist as it looks to build US operations for health care business. Lundbeck and Novo Nordisk among investors that will see an exit.